Goldschmidt Cancer Center

Oncology • Jefferson City, MO

Home/Jefferson City/Oncology/Goldschmidt Cancer Center

About

Goldschmidt Cancer Center in Jefferson City, Missouri offers advanced cancer services and treatment. Located at 1432 Southwest Boulevard, the center features an on-site infusion pharmacy and lab, a healing garden, chapel, and patient education resource center. The clinic is open Monday through Friday from 8:00 am to 4:30 pm, with lab hours from 7:30 am to 4:00 pm.

Book appointment Call clinic Visit website Get directions

Clinic Type

Oncology

Address

1432 Southwest Blvd PO Box 1128

Phone

573-632-4800

Email

websupport@health.missouri.edu

Opening Hours

On-site infusion pharmacy and lab. Open 7:30 a.m. - 4 p.m. (excluding holidays)

Website

https://www.muhealth.org/locations/goldschmidt-cancer-center

Services Offered

—

Insurance & Payment

—

Languages Spoken

—

FAQs

What are the clinic hours?

Location Hours: Monday–Friday 8:00 am–4:30 pm; Lab Hours: On-site infusion pharmacy and lab; Open 7:30 a.m. – 4 p.m. (excluding holidays).

Social Media

Tiktok Twitter Youtube Facebook Instagram

Photos

What Patients Say

Overall sentiment across review platforms: mixed

Birdeye: 4.5/5 stars (81 reviews)

Patients praise

Appreciation for professional, caring, and friendly staff and doctors
Helpful and personable atmosphere for some patients
Convenience of having local cancer care services

Common complaints

Negative feedback regarding staff communication and attitude
Complaints about administrative issues such as scheduling and paperwork processing
Concerns regarding delays in diagnosis and testing

"HORRIBLE EXPERIENCE. I have never been so disgusted by a hospital in my life! Terrible attitudes from nurses, front desk, all of it."

— Birdeye user review

"Can't say enough good things about the doctors and staff here. Always friendly, always caring. I hope that you never need these people, but if you do......you will be in great hands."

— Yelp user review via MapQuest

Synthesized from public review platforms as of Jul 11, 2026 — sources: [1][2][3][4].